AAPG NASDAQ
Ascentage Pharma Group International
1W: -8.0%
1M: -1.6%
3M: -20.0%
YTD: -44.4%
1Y: -58.7%
$14.85
-0.60 (-3.88%)
Weekly Expected Move ±10.2%
$12
$14
$15
$17
$18
Credit Risk of going bust: higher than 70% of companies Debt: 18.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.61 (down 96%), Ascentage Pharma Group International would be worth roughly what it owes.
Total debt $314.8M against a stock market value of $1.38B.
Distance to default 3.42 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $267.2M (short-term plus half of long-term), stock volatility 59.8%; Altman Z'' -9.70. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $314.8M against a stock market value of $1.38B.
Distance to default 3.42 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $267.2M (short-term plus half of long-term), stock volatility 59.8%; Altman Z'' -9.70. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.